Trial intelligence / Profile preview

Dexmedetomidine for Anesthesia Neurotoxicity in Children

NCT03234660Completed

Sponsor
Seoul National University Hospital
Start
Sep 2017
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in anesthesia-induced neurotoxicity (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Glial Fibrillary Acidic Protein. Started Sep 2017; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

anesthesia-induced neurotoxicity

Beyond the preview

Go deeper on NCT03234660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03234660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call